Guidelines on the diagnosis, investigation and initial treatment of myeloma: a British Society for Haematology/UK Myeloma Forum Guideline

Br J Haematol. 2021 Apr;193(2):245-268. doi: 10.1111/bjh.17410. Epub 2021 Mar 21.

Authors

Jonathan Sive¹, Kirsty Cuthill², Hannah Hunter³, Majid Kazmi⁴, Guy Pratt⁵, Dean Smith⁶; British Society of Haematology

Affiliations

¹ University College London Hospitals NHS Foundation Trust, London, UK.
² Kings College Hospital NHS Foundation Trust, London, UK.
³ University Hospitals Plymouth NHS Trust, Plymouth, UK.
⁴ Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁶ Nottingham University Hospitals NHS Trust, Nottingham, UK.

PMID: 33748957
DOI: 10.1111/bjh.17410

No abstract available

Publication types

Practice Guideline

MeSH terms

Aged
Aged, 80 and over
Allografts / transplantation
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy / methods
Bone Marrow* / pathology
Clinical Trials as Topic
Cytogenetic Analysis / standards
Diagnostic Imaging / standards
Diagnostic Imaging / trends
Early Detection of Cancer / standards
Electrophoresis / methods
Hematology* / organization & administration
Humans
Immunoglobulin alpha-Chains / immunology
Immunotherapy / methods
Immunotherapy, Adoptive / methods
In Situ Hybridization, Fluorescence / standards
Middle Aged
Multiple Myeloma* / blood
Multiple Myeloma* / diagnosis
Multiple Myeloma* / mortality
Multiple Myeloma* / therapy
Neoplasm Staging / standards
Patient Selection / ethics
Practice Guidelines as Topic
Prognosis
Proteasome Inhibitors / therapeutic use
United Kingdom / epidemiology

Substances

Immunoglobulin alpha-Chains
Proteasome Inhibitors